CIK 0000073290 · Non-accelerated filer<br>Smaller reporting company
BIOMERICA INC
Sign in to watch- Ticker
- BMRA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 952645573
- Phone
- 9493792875
- Business address
- 17571 VON KARMAN AVENUE, IRVINE, CA, 92614
- Open-market buys, last 90 days
- $158,000
- in 5 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$158,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 20 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-06 | Lu Gary Chief Financial Officer | Grant or award · Non-qualified stock option | +100,000 | 100,000 | ||
| 2023-01-27 | BARBIERI ALLEN Executive Vice Chairman | Purchase | +1,538 | $2.94 | $5K | 101,327 |
| 2023-01-26 | Coste Catherine Director | Purchase | +2,190 | $2.96 | $6K | 43,790 |
| 2023-01-25 | Irani Zackary S. Chief Executive Officer | Purchase | +1,800 | $2.85 | $5K | 1,005,960 |
| 2023-01-24 | Irani Zackary S. Chief Executive Officer | Purchase | +2,000 | $2.81 | $6K | 1,004,160 |
| 2021-12-09 | Irani Zackary S. Chief Executive Officer | Grant or award · Non-qualified stock option | +100,000 | 733,616 | ||
| 2021-12-09 | Sloan Steven Chief Financial Officer | Grant or award · Non-qualified stock option | +40,000 | 115,000 | ||
| 2021-12-09 | Sirgo Mark A Director | Grant or award · Non-qualified stock option | +25,000 | 170,000 | ||
| 2021-12-09 | BARBIERI ALLEN Director | Grant or award · Non-qualified stock option | +45,000 | 265,000 | ||
| 2021-12-09 | Emerson Jane Director | Grant or award · Non-qualified stock option | +25,000 | 190,000 | ||
| 2021-12-09 | Coste Catherine Director | Grant or award · Non-qualified stock option | +25,000 | 70,000 | ||
| 2020-12-10 | CANO FRANCIS Director | Grant or award · Non-qualified stock option | +20,000 | 175,000 | ||
| 2020-12-10 | Emerson Jane Director | Grant or award · Non-qualified stock option | +20,000 | 165,000 | ||
| 2020-12-10 | Coste Catherine Director | Grant or award · Non-qualified stock option | +20,000 | 45,000 | ||
| 2020-12-10 | Sirgo Mark A Director | Grant or award · Non-qualified stock option | +20,000 | 145,000 | ||
| 2020-12-10 | BARBIERI ALLEN Director | Grant or award · Non-qualified stock option | +30,000 | 220,000 | ||
| 2020-12-10 | Sloan Steven Chief Financial Officer | Grant or award · Non-qualified stock option | +25,000 | 75,000 | ||
| 2020-12-10 | Irani Zackary S. Chief Executive Officer | Grant or award · Non-qualified stock option | +78,616 | 633,616 | ||
| 2020-10-26 | Coste Catherine Director | Purchase | +9,100 | $5.45 | $50K | 9,100 |
| 2020-10-05 | CANO FRANCIS Director | Gift | −20,000 | 146,736 |
Page 3 of 16 · 303 trades